Lifecare AS
OSE:LIFE
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
12.6
55.8363
|
Price Target |
|
We'll email you a reminder when the closing price reaches NOK.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Net Margin
Lifecare AS
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Net Margin Across Competitors
Country | NO |
Market Cap | 213.2m NOK |
Net Margin |
-269%
|
Country | US |
Market Cap | 204.9B USD |
Net Margin |
14%
|
Country | US |
Market Cap | 195.2B USD |
Net Margin |
29%
|
Country | US |
Market Cap | 146.7B USD |
Net Margin |
16%
|
Country | US |
Market Cap | 132.6B USD |
Net Margin |
11%
|
Country | IE |
Market Cap | 110.6B USD |
Net Margin |
12%
|
Country | US |
Market Cap | 64.7B USD |
Net Margin |
9%
|
Country | DE |
Market Cap | 55.6B EUR |
Net Margin |
8%
|
Country | CN |
Market Cap | 319.2B CNY |
Net Margin |
34%
|
Country | US |
Market Cap | 41.6B USD |
Net Margin |
74%
|
Country | US |
Market Cap | 37.7B USD |
Net Margin |
9%
|
Lifecare AS
Glance View
Lifecare AS engages in the research, testing, and development of medical sensors for health monitoring. The company is headquartered in Bergen, Hordaland. The company went IPO on 2018-07-10. Lifecare's activities are concentrated on the development of sensor for use as a medical product, initially the sensor Sencell for continuous monitoring of glucose (blood sugar) for people with diabetes. The technology is suitable for detecting and measuring a wide range of molecules that can occur in the human body, based on variations in osmotic pressure.
See Also
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Based on Lifecare AS's most recent financial statements, the company has Net Margin of -269.4%.